Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT01569269
Eligibility Criteria:
Inclusion Criteria:
* participants must be of at least 18 years of age,
* participants must have persistent symptoms of CIPN resulting from treatment with vinca alkaloid, taxane, platinum class chemotherapies or immunomodulators (Thalidomide) or antineoplastic agents (Velcade) for a known cancer diagnosis
* participants must have completed chemotherapy at least three months prior to beginning the study,
* participants cannot concurrently receive chemotherapy treatment for cancer, nor
* actively take part in one of the complementary modalities offered in this pilot study.
* participants will be required to have an ability to comfortably speak, read, and understand English.
* participants must be fully oriented and possess the capacity to understand and provide informed consent for participation in the study.
Exclusion Criteria:
* failure to meet any one of the inclusion criteria
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT01569269
Study Brief:
Protocol Section:
NCT01569269